Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Defining the fetal origin of MLL-AF4 infant leukemia highlights specific fatty acid requirements. | Cell Rep | 2021 | 34706236 | PubTator, text mining | PubMed |
| Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo. | Nat Commun | 2021 | 34697318 | PubTator, text mining | PubMed |
| Comprehensive Bioinformatics Analysis to Identify the Gene HMMR Associated With Lung Adenocarcinoma Prognosis and Its Mechanism of Action in Multiple Cancers. | Front Oncol | 2021 | 34692489 | PubTator, text mining | PubMed |
| A Unified Transcriptional, Pharmacogenomic, and Gene Dependency Approach to Decipher the Biology, Diagnostic Markers, and Therapeutic Targets Associated with Prostate Cancer Metastasis. | Cancers (Basel) | 2021 | 34680307 | PubTator, text mining | PubMed |
| Hyaluronic Acid: A Key Ingredient in the Therapy of Inflammation. | Biomolecules | 2021 | 34680150 | PubTator, text mining | PubMed |
| 4-Methylumbelliferone induces antitumor effects independently of hyaluronan synthesis inhibition in human acute leukemia cell lines. | Life Sci | 2021 | 34678263 | PubTator, text mining | PubMed |
| Translational Application of 3D Bioprinting for Cartilage Tissue Engineering. | Bioengineering (Basel) | 2021 | 34677217 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Acetylation-Related lncRNAs and Identified AC099850.3 as Prognostic Biomarker in Non-Small Cell Lung Cancer. | J Oncol | 2021 | 34675976 | PubTator, text mining | PubMed |
| Natural Presentation of Glycosaminoglycans in Synthetic Matrices for 3D Angiogenesis Models. | Front Cell Dev Biol | 2021 | 34671601 | PubTator, text mining | PubMed |
| Introducing Hyaluronic Acid into Supramolecular Polymers and Hydrogels. | Biomacromolecules | 2021 | 34662095 | PubTator, text mining | PubMed |
| The Effect of Smoking on the Immune Microenvironment and Immunogenicity and Its Relationship With the Prognosis of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer. | Front Cell Dev Biol | 2021 | 34660603 | PubTator, text mining | PubMed |
| LC-MS Based Metabolomics Study of the Effects of EGCG on A549 Cells. | Front Pharmacol | 2021 | 34650434 | PubTator, text mining | PubMed |
| Survivin' Acute Myeloid Leukaemia-A Personalised Target for inv(16) Patients. | Int J Mol Sci | 2021 | 34638823 | PubTator, text mining | PubMed |
| RHAMM Is a Multifunctional Protein That Regulates Cancer Progression. | Int J Mol Sci | 2021 | 34638654 | PubTator, text mining | PubMed |
| Matters of size: Roles of hyaluronan in CNS aging and disease. | Ageing Res Rev | 2021 | 34634492 | PubTator, text mining | PubMed |
| Antitumor effect of 4MU on glioblastoma cells is mediated by senescence induction and CD44, RHAMM and p-ERK modulation. | Cell Death Discov | 2021 | 34628469 | PubTator, text mining | PubMed |
| HMMR is a downstream target of FOXM1 in enhancing proliferation and partial epithelial-to-mesenchymal transition of bladder cancer cells. | Exp Cell Res | 2021 | 34624323 | PubTator, text mining | PubMed |
| A rare unbalanced translocation (trisomy 5q33.3-qter, monosomy 13q34-qter) results in growth hormone deficiency and brain anomalies. | Mol Genet Genomic Med | 2021 | 34623774 | PubTator, text mining | PubMed |
| Multipeptide stimulated PBMCs generate TEM/TCM for adoptive cell therapy in multiple myeloma. | Oncotarget | 2021 | 34611479 | PubTator, text mining | PubMed |
| Identification of a glycolysis-related gene signature for survival prediction of ovarian cancer patients. | Cancer Med | 2021 | 34609082 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers?page=36